Advancing biologics production through Oxford Nanopore whole-genome sequencing
)
Optimising biologics production is crucial for making patient treatments more affordable and scalable. In this study, researchers at Lonza focus on improving biologics expression in Chinese hamster ovary (CHO) cells using transposon-mediated systems.
This poster demonstrates how Oxford Nanopore sequencing is a powerful tool for uncovering the genetic and epigenetic landscape of production cell lines — essential for next-generation biologics development.
